Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARTIST II: Adjuvant Chemotherapy in Gastric Cancer
NCT01761461Phase 3Unknown
- Sponsor
- Samsung Medical Center
- Start
- Feb 2013
- Primary completion
- Dec 2020
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of oxaliplatin in gastric adenocarcinoma, sponsored by Samsung Medical Center. Status: unknown.
02
Drugs
oxaliplatin
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT01761461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01761461.